Dupilumab for treating adults with moderate to severe atopic dermatitis.

Rodolfo Andres Hernandez, Moira Cruickshank, Maria Petrova Dimitrova, David John Cooper, Lorna Sharman Aucott, Cynthia Fraser, Michal Shimonovich, Anthony Ormerod, Graham Stewart Scotland, Miriam Giovanna Brazzelli

Research output: Book/ReportCommissioned Report

Original languageEnglish
PublisherEvidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence
VolumeTA534
Publication statusPublished - 1 Aug 2018

Cite this

Hernandez, R. A., Cruickshank, M., Dimitrova, M. P., Cooper, D. J., Aucott, L. S., Fraser, C., ... Brazzelli, M. G. (2018). Dupilumab for treating adults with moderate to severe atopic dermatitis. Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence.

Dupilumab for treating adults with moderate to severe atopic dermatitis. / Hernandez, Rodolfo Andres; Cruickshank, Moira; Dimitrova, Maria Petrova; Cooper, David John; Aucott, Lorna Sharman; Fraser, Cynthia; Shimonovich, Michal ; Ormerod, Anthony; Scotland, Graham Stewart; Brazzelli, Miriam Giovanna.

Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence, 2018.

Research output: Book/ReportCommissioned Report

Hernandez, RA, Cruickshank, M, Dimitrova, MP, Cooper, DJ, Aucott, LS, Fraser, C, Shimonovich, M, Ormerod, A, Scotland, GS & Brazzelli, MG 2018, Dupilumab for treating adults with moderate to severe atopic dermatitis. vol. TA534, Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence.
Hernandez RA, Cruickshank M, Dimitrova MP, Cooper DJ, Aucott LS, Fraser C et al. Dupilumab for treating adults with moderate to severe atopic dermatitis. Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence, 2018.
Hernandez, Rodolfo Andres ; Cruickshank, Moira ; Dimitrova, Maria Petrova ; Cooper, David John ; Aucott, Lorna Sharman ; Fraser, Cynthia ; Shimonovich, Michal ; Ormerod, Anthony ; Scotland, Graham Stewart ; Brazzelli, Miriam Giovanna. / Dupilumab for treating adults with moderate to severe atopic dermatitis. Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence, 2018.
@book{5a4b7d9707b94496b41f8e1d517adf3c,
title = "Dupilumab for treating adults with moderate to severe atopic dermatitis.",
author = "Hernandez, {Rodolfo Andres} and Moira Cruickshank and Dimitrova, {Maria Petrova} and Cooper, {David John} and Aucott, {Lorna Sharman} and Cynthia Fraser and Michal Shimonovich and Anthony Ormerod and Scotland, {Graham Stewart} and Brazzelli, {Miriam Giovanna}",
year = "2018",
month = "8",
day = "1",
language = "English",
volume = "TA534",
publisher = "Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence",

}

TY - BOOK

T1 - Dupilumab for treating adults with moderate to severe atopic dermatitis.

AU - Hernandez, Rodolfo Andres

AU - Cruickshank, Moira

AU - Dimitrova, Maria Petrova

AU - Cooper, David John

AU - Aucott, Lorna Sharman

AU - Fraser, Cynthia

AU - Shimonovich, Michal

AU - Ormerod, Anthony

AU - Scotland, Graham Stewart

AU - Brazzelli, Miriam Giovanna

PY - 2018/8/1

Y1 - 2018/8/1

M3 - Commissioned Report

VL - TA534

BT - Dupilumab for treating adults with moderate to severe atopic dermatitis.

PB - Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence

ER -